Model Integration and Configuration for Pharmacoeconomics

Data Characteristics in Pharmacoeconomics

Pharmacoeconomics data originates from clinical trial reports, real-world evidence (RWE) studies, health insurance reimbursement policies, drug pricing information, and various Health Technology Assessment (HTA) reports. Data update frequencies vary. Clinical trial data typically releases with study progress. RWE data may update annually or over longer periods. Health insurance policies and drug pricing are highly time-sensitive and require close monitoring of policy changes. Document structures are diverse. They include structured tabular data (e.g., input-output tables in cost-effectiveness analysis), semi-structured research reports (containing statistical data and textual descriptions), and unstructured policy interpretations and expert opinions. Fields cover drug purchase prices, treatment costs, disease burden, Quality-Adjusted Life Year (QALY) gains, adverse event rates, and treatment costs. Units involve currency (e.g., USD, EUR), time (e.g., year, month), ratios (e.g., percentage), and utility values (e.g., QALY).

Constraints on Model Integration and Configuration

The high heterogeneity and varied update frequencies of pharmacoeconomics data impose specific requirements on model integration. First, processing data from different sources and with diverse structures is necessary. This means knowledge base construction must support multi-format document parsing and flexible metadata tagging. Second, data timeliness, especially for health insurance policies and drug pricing, requires the knowledge base to have incremental update and version management capabilities. This ensures the model always bases its inferences on the latest information. For example, changes in a drug's reimbursement scope or price directly affect its economic evaluation results. Additionally, the complex field units require the model to correctly distinguish and apply these units during understanding and generation, avoiding misjudgments due to unit confusion. For instance, calculating the cost-effectiveness ratio requires precise identification of currency and utility units for costs and benefits. This directly impacts the semantic understanding depth and matching accuracy of vectorization models.

Configuration Settings

Configuration Item	Recommended Value	Rationale
`Chunk size` (Segment Length)	`800–1200 characters` (characters)	Balances the completeness of economic report paragraphs with model processing capacity.
`Recall count` (Recall Count)	`Top 10 entries` (top 10)	Ensures coverage of key information from multiple data sources.
`Similarity threshold` (Similarity Threshold)	`0.78–0.85`	Adapts to the precise matching requirements of economic terminology.
`Rerank result count` (Rerank Return Count)	`Top 5 entries` (top 5)	Improves the relevance and accuracy of final results.
`embedding_model`	`text-embedding-3-large`	Enhances understanding of complex economic concepts and multi-unit data.
`maxContext`	`4000 token`	Handles longer policy documents and research reports.

Common Pitfalls

Knowledge base index updates are not timely, causing the model to cite outdated drug prices or health insurance policies. This occurs due to the lack of a periodic or triggered data synchronization mechanism.
The model confuses units during cost-benefit calculations, for example, directly adding USD and EUR. This happens because field units were not standardized or metadata tagged during data import.
After importing large amounts of structured tabular data, some field content is truncated or parsed incorrectly, preventing the model from obtaining complete numerical information. This is because the file parser's PARSE_FILE_TIMEOUT_SECONDS is too short or it incorrectly identifies the table structure.

Verification of Configuration

Import a batch of pharmacoeconomics reports containing recent policy changes and price adjustments. Check if the model can accurately identify and cite the latest data.
For typical cost-benefit analysis scenarios, input queries. Verify if the currency and utility units in the model's output are correct by comparing them with the original data.
Randomly select several key pharmacoeconomics concepts (e.g., QALY, ICER). Test the model's understanding of their definitions and calculation methods to ensure accurate explanations.
Check the knowledge base's index status and update logs. Confirm that all newly imported or updated data has been successfully indexed and that the indexing model performs as expected.

The values provided are common starting points and should be measured against the reader's own samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.